About the Journal

Drug Development & Therapeutics is an international, open access, peer-reviewed journal that publishes: Original Research; Reviews; Hypothesis formation and commentaries that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.

The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict double blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).

The general criteria for acceptance of a manuscript are:

• advances Angiogenesis and herbal therapeutics based scientific knowledge;

• advances translational research;

• provides an adequate and relevant literature review;

• utilizes scientifically solid, reliable, and reproducible methodologies;

• derives appropriate and justifiable conclusions based upon the experimental data presented; and

• is written in English and is of the utmost quality and clarity.

Drug Development & Therapeutics is dedicated to the dissemination of fundamental information related to the clinical and pre-clinical research on system and chemical biology. Full-length articles presenting the results of original research, Review, Data report and brief communications are featured. The Journal publish article continuously. All accepted manuscripts are granted free online open-access immediately after publication, which permits its users to read, download, copy, distribute, print, search, or link to the full texts of its articles, thus facilitating access to a broad readership.

Drug Development & Therapeutics facilitates the author's response to the NIH Public Access Policy. For more details please see the Guide for authors.

Journal Officials Editor-in-Chief, Executive Editor, Assistant Editors, Section Editors, and Production Editors.

Publisher
EMAN Research

ISSN

print :XXXX; online:XXXX.

Frequency Continuous

Ranking: Drug discovery

Drug Development & Therapeutics facilitates the author's response to the NIH Public Access Policy. For more details please see the Guide for authors.

Indexing

CrossRef, Publons, Google Scholar, Researchgate, Cite Factor.

Submitted for indexing